Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
20th Anniversary
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Decentralized Clinical Trials (DCTs)
Site Management (SMO)
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
Environment, Social and Governance
(ESG)
We create sustainable values. We live our values.
Contributing to Global Health and Well-being
Tigermed’s mission is to “Advance human health through delivery
excellence”, based on which it focuses on solving the most challenging global health problems,
meeting the unmet medical needs of patients, creating social value and benefiting human
health.
As a pioneer in the globalization of clinical CRO in China, Tigermed has
close customers and industry partners as well as a senior professional management team to
constantly explore innovative solutions to meet the diverse needs of our customers and make
greater contributions to pharmaceutical innovation and R&D to create social
value.
MSCI ESG RatingsAA
CDP Climate Change QuestionnaireB
Sustainalytics15.4 （low risk）
SZSE's CNI ESG RatingsAAA
Ecovadis56
2023 Zhejiang Province Excellent Corporate Social Responsibility Excellent ESG Case Studies of Enterprises
2024 Hangzhou Listed Companies' ESG Strategy and Philanthropy Impact Ranking "Top 20 Pioneers"
2024 Chinese Pharmaceutical Listed Companies in ESG Competitiveness Top 20
Tigermed’s Sustainable Development Strategies
As a leading integrated biopharmaceutical R&D service platform, Tigermed continues to support and contribute to the United Nations Sustainable Development Goals (SDGs), forging ahead with fortitude taking “Contributing to global health and well-being” as the core. While realizing our economic growth and sustainable development, the Company identify 4 key aspects of sustainable development related to our own operations and growth, and draw up corresponding strategic guidelines for the four key areas.
